Next-generation targeted protein degradation biotech company developing monovalent degraders for cancer, neurodegeneration, and other diseases using proprietary AI-integrated drug discovery platforms.
Create a free account to see full funding history, valuations, and investor participation.
Create Free AccountCreate a free account to see which investors have funded this company.
Create Free Account